Abstract:Background The increasing incidence of inflammatory bowel disease (IBD) has imposed heavy financial burdens for Chinese patients; however, data about their financial status and access to health care are still lacking. This information is important for informing patients with IBD about disease treatment budgets and health care strategies. Objective The aim of this study was to evaluate the economic status and medical care access of patients with IBD through the China Crohn’s & Colitis Foundation web-based platform in China. Methods Our study was performed in 14 IBD centers in mainland China between 2018 and 2019 through WeChat. Participants were asked to complete a 64-item web-based questionnaire. Data were collected by the Wenjuanxing survey program. We mainly focused on income and insurance status, medical costs, and access to health care providers. Respondents were stratified by income and the associations of income with medical costs and emergency visit times were analyzed. Results In this study, 3000 patients with IBD, that is, 1922 patients with Crohn disease, 973 patients with ulcerative colitis, and 105 patients with undetermined colitis were included. During the last 12 months, the mean (SD) direct and indirect costs for per patient with IBD were approximately US $11,668.68 ($7944.44) and US $74.90 ($253.60) in China. The average reimbursement ratios for most outpatient and inpatient costs were less than 50%. However, the income of 85.5% (2565/3000) of the patients was less than ¥10,000 (US $1445) per month. Approximately 96.5% (2894/3000) of the patients were covered by health insurance, but only 24.7% (741/3000) of the patients had private commercial insurance, which has higher imbursement ratios. Nearly 98.0% (2954/3000) of the patients worried about their financial situation. Thus, 79.7% (2392/3000) of the patients with IBD tried to save money for health care and even delayed their medical treatments. About half of the respondents (1282/3000, 42.7%) had no primary care provider, and 52.2% (1567/3000) of the patients had to visit the emergency room 1-4 times per year for the treatment of their IBD. Multivariate analysis revealed that lower income (P=.001) and higher transportation (P=.004) and accommodation costs (P=.001) were significantly associated with the increased number of emergency visits of the patients. Conclusions Chinese patients with IBD have enormous financial burdens and difficulties in accessing health care, which have increased their financial anxiety and inevitably influenced their disease outcomes. Early purchase of private insurance, thereby increasing the reimbursement ratio for medical expenses, and developing the use of telemedicine would be effective strategies for saving on health care costs.

S1279 IBD Care in Patients of Color: A Qualitative Analysis

IDDF2018-ABS-0223 an Eastern Chinese Multicenter Survey on Health-Related Quality of Life in Inflammatory Bowel Disease Patients and Disease-Related Perception of Caregivers

Racial and Ethnic Disparities in Patients With Inflammatory Bowel Disease: An Online Survey

Culturally Sensitive and Inclusive IBD Care

S1324 Racial Disparity for IBD Manifestation and Treatment in an Urban General GI Clinic Population

Economic Burden and Health Care Access for Patients with Inflammatory Bowel Diseases in China: Web-Based Survey Study

Challenging the Surge of IBD: The role of the China Crohn’s and Colitis Foundation in the healthcare landscape of IBD

S1123 Underrepresentation of Minorities in the Major Biologics Trials for Crohn's Disease

Healthcare Utilization and Geographic Distribution of Advanced Therapy in Minority Race and Ethnic Groups With Inflammatory Bowel Disease

Racial and ethnic disparities in clinical presentation, management, and outcomes of patients with inflammatory bowel disease: a narrative review

S1251 Clinical Trial Characteristics of Inflammatory Bowel Disease Trials Influencing Reporting and Representation of Race and Ethnicity on ClinicalTrials.gov

Social barriers influence inflammatory bowel disease (IBD) outcomes and disproportionally affect Hispanics and non-Hispanic Blacks with IBD

Inflammatory bowel disease in young patients: challenges faced by black and minority ethnic communities in the UK

S1112 Trends in the Prevalence of Diagnosed Inflammatory Bowel Disease among Asian Subgroups in a Large Northern California Population

Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Studies

S1275 Geographic and Temporal Differences in Inflammatory Bowel Disease Patient Concerns Across the World: A Comprehensive Review

S1184 Racial Differences in the Use of and Suboptimal Clinical Responses to Anti-TNF Therapy for Patients with Inflammatory Bowel Disease

Quality of Care for Patients with Inflammatory Bowel Disease in East China

Differences in provider recommendations for Black/African American and White patients with irritable bowel syndrome

Uncovering Unique Needs And Barriers To Care Among Lgbtq+ Patients With Ibd: Insights From A Community Survey To Inform Inclusive Practices

S1245 Racial Disparities in Clinical Manifestation of Crohn's Disease